ID
40156
Beschreibung
Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid
Stichworte
Versionen (1)
- 18.03.20 18.03.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
18. März 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455
Visit 2 - Pain Assessment VAS Score; Patient's Global Assessment of Arthritis Condition VAS Score; Physician's Global Assessment of Arthritis Condition VAS Score
Beschreibung
Patient's Global Assessment of Arthritis Condition VAS Score
Alias
- UMLS CUI-1
- C0281858
- UMLS CUI-2
- C0003864
- UMLS CUI-3
- C0449438
- UMLS CUI-4
- C0449820
Beschreibung
Arthritis Condition VAS Score - Assessment Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0003864
- UMLS CUI [1,2]
- C0449438
- UMLS CUI [1,3]
- C0449820
- UMLS CUI [2]
- C2985720
Beschreibung
VAS Score
Datentyp
integer
Alias
- UMLS CUI [1]
- C2960751
Beschreibung
Patient's Global Assessment of Arthritis Condition VAS Score - ISO Language code
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0281858
- UMLS CUI [1,2]
- C0003864
- UMLS CUI [1,3]
- C0449438
- UMLS CUI [1,4]
- C0449820
- UMLS CUI [2]
- C1708640
Beschreibung
Physician's Global Assessment of Arthritis Condition VAS Score
Alias
- UMLS CUI-1
- C0281858
- UMLS CUI-2
- C0003864
- UMLS CUI-3
- C0449438
- UMLS CUI-4
- C0449820
- UMLS CUI-5
- C0031831
Beschreibung
Physician's Global Assessment of Arthritis Condition VAS Score - Assessment Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0003864
- UMLS CUI [1,2]
- C0449438
- UMLS CUI [1,3]
- C0449820
- UMLS CUI [1,4]
- C0031831
- UMLS CUI [2]
- C2985720
Beschreibung
Physician's Global Assessment of Arthritis Condition VAS Score -VAS Score
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0003864
- UMLS CUI [1,2]
- C0449438
- UMLS CUI [1,3]
- C0449820
- UMLS CUI [1,4]
- C0031831
Beschreibung
Physician's Global Assessment of Arthritis Condition VAS Score - ISO Language code
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0003864
- UMLS CUI [1,2]
- C0449438
- UMLS CUI [1,3]
- C0449820
- UMLS CUI [1,4]
- C0031831
- UMLS CUI [2]
- C1708640
Ähnliche Modelle
Visit 2 - Pain Assessment VAS Score; Patient's Global Assessment of Arthritis Condition VAS Score; Physician's Global Assessment of Arthritis Condition VAS Score
C0042815 (UMLS CUI-2)
C0042815 (UMLS CUI [1,2])
C1161170 (UMLS CUI [2,1])
C0042815 (UMLS CUI [2,2])
C2985720 (UMLS CUI [2,3])
C0042815 (UMLS CUI [1,2])
C0042815 (UMLS CUI [1,2])
C1708640 (UMLS CUI [2])
C0003864 (UMLS CUI-2)
C0449438 (UMLS CUI-3)
C0449820 (UMLS CUI-4)
C0449438 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C2985720 (UMLS CUI [2])
C0003864 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,3])
C0449820 (UMLS CUI [1,4])
C1708640 (UMLS CUI [2])
C0003864 (UMLS CUI-2)
C0449438 (UMLS CUI-3)
C0449820 (UMLS CUI-4)
C0031831 (UMLS CUI-5)
C0449438 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0031831 (UMLS CUI [1,4])
C2985720 (UMLS CUI [2])
C0449438 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0031831 (UMLS CUI [1,4])
C0449438 (UMLS CUI [1,2])
C0449820 (UMLS CUI [1,3])
C0031831 (UMLS CUI [1,4])
C1708640 (UMLS CUI [2])
Keine Kommentare